BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-03-11
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1808
- Registration Number
- NCT04304508
- Locations
- 🇺🇸
Guilford Neurologic Associates, Greensboro, North Carolina, United States
🇦🇺Fiona Stanley Hospital, Murdoch, Western Australia, Australia
🇦🇺John Hunter Hospital, New Lambton, New South Wales, Australia
Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)
- First Posted Date
- 2020-03-06
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 300
- Registration Number
- NCT04298567
- Locations
- 🇮🇳
Many locations, Multiple Locations, India
Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 25000
- Registration Number
- NCT04297072
- Locations
- 🇬🇧
Many locations, Multiple Locations, United Kingdom
Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body
- First Posted Date
- 2020-02-24
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 4301
- Registration Number
- NCT04281147
- Locations
- 🇨🇦
Multiple Locations, Multiple Locations, Canada
Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 24
- Registration Number
- NCT04275960
- Locations
- 🇩🇪
CRS Clinical-Research-Services Mannheim GmbH, Mannheim, Baden-Württemberg, Germany
ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-02-13
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 14
- Registration Number
- NCT04267939
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-12
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 36
- Registration Number
- NCT04265781
- Locations
- 🇯🇵
Hakata Clinic, Fukuoka, Japan
Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-11
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 110
- Registration Number
- NCT04264637
- Locations
- 🇨🇦
Cliantha Research, Mississauga, Ontario, Canada
Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 14
- Registration Number
- NCT04252300
- Locations
- 🇺🇸
Covance Clinical Research Unit, Inc., Daytona Beach, Florida, United States
PRECISE, a Study to Gather More Information About Bone Fractures and Survival in Castration-resistant PRostate Cancer (CRPC) patiEnts Treated With Radium-223 in Routine Clinical practIce in SwedEn
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1434
- Registration Number
- NCT04256993
- Locations
- 🇸🇪
Database Study, Database Study, Sweden
© Copyright 2024. All Rights Reserved by MedPath